SEC Form 4 · accession 0001209191-17-046041
CymaBay Therapeutics, Inc. · CBAY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles McWherter
Officer — SVP & Chief Scientific Officer
Period of report
Jul 20, 2017
Accepted (ET)
Jul 24, 2017 · 6:19 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001042074
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 20, 2017 | P | 100 | $7.42 | A | 5,100 | D | |
| Common Stock | Jul 20, 2017 | P | 3,000 | $7.4268 | A | 8,100 | D | |
| Common Stock | Jul 20, 2017 | P | 200 | $7.428 | A | 8,300 | D | |
| Common Stock | Jul 20, 2017 | P | 1,700 | $7.429 | A | 10,000 | D |
Table II — derivative securities
No Table II lines on this filing.